• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga's Top Ratings Upgrades, Downgrades For October 9, 2023

    10/9/23 11:00:26 AM ET
    $APO
    $ARM
    $ARMK
    $AVAV
    Investment Managers
    Finance
    Semiconductors
    Technology
    Get the next $APO alert in real time by email

    Upgrades

    Scotiabank upgraded the previous rating for Mirati Therapeutics Inc (NASDAQ:MRTX) from Sector Underperform to Sector Perform. For the second quarter, Mirati Therapeutics had an EPS of $3.04, compared to year-ago quarter EPS of $3.18. At the moment, the stock has a 52-week-high of $101.20 and a 52-week-low of $27.30. Mirati Therapeutics closed at $60.20 at the end of the last trading period.

    According to Loop Capital, the prior rating for MSC Industrial Direct Co Inc (NYSE:MSM) was changed from Hold to Buy. For the third quarter, MSC Industrial Direct Co had an EPS of $1.74, compared to year-ago quarter EPS of $1.82. The stock has a 52-week-high of $103.95 and a 52-week-low of $72.97. At the end of the last trading period, MSC Industrial Direct Co closed at $99.72.

    For Patterson-UTI Energy Inc (NASDAQ:PTEN), Citigroup upgraded the previous rating of Neutral to Buy. Patterson-UTI Energy earned $0.43 in the second quarter, compared to $0.05 in the year-ago quarter. The stock has a 52-week-high of $19.81 and a 52-week-low of $9.70. At the end of the last trading period, Patterson-UTI Energy closed at $12.32.

    According to Evercore ISI Group, the prior rating for Oracle Corp (NYSE:ORCL) was changed from In-Line to Outperform. In the first quarter, Oracle showed an EPS of $1.19, compared to $1.03 from the year-ago quarter. The stock has a 52-week-high of $127.54 and a 52-week-low of $61.66. At the end of the last trading period, Oracle closed at $109.96.

    For Lennox International Inc (NYSE:LII), Goldman Sachs upgraded the previous rating of Sell to Buy. For the second quarter, Lennox Intl had an EPS of $6.15, compared to year-ago quarter EPS of $5.00. The stock has a 52-week-high of $393.02 and a 52-week-low of $203.82. At the end of the last trading period, Lennox Intl closed at $373.62.

    For Aramark (NYSE:ARMK), Jefferies upgraded the previous rating of Hold to Buy. For the third quarter, Aramark had an EPS of $0.36, compared to year-ago quarter EPS of $0.25. At the moment, the stock has a 52-week-high of $45.72 and a 52-week-low of $23.95. Aramark closed at $24.60 at the end of the last trading period.

    According to Baird, the prior rating for On Holding AG (NYSE:ONON) was changed from Neutral to Outperform. On Holding earned $0.04 in the second quarter, compared to $0.15 in the year-ago quarter. The stock has a 52-week-high of $37.08 and a 52-week-low of $15.44. At the end of the last trading period, On Holding closed at $25.11.

    For Zscaler Inc (NASDAQ:ZS), Barclays upgraded the previous rating of Equal-Weight to Overweight. Zscaler earned $0.64 in the fourth quarter, compared to $0.25 in the year-ago quarter. The current stock performance of Zscaler shows a 52-week-high of $185.90 and a 52-week-low of $84.93. Moreover, at the end of the last trading period, the closing price was at $163.59.

    See all analyst ratings upgrades.

    Downgrades

    Ladenburg Thalmann downgraded the previous rating for Dynatronics Corp (NASDAQ:DYNT) from Buy to Neutral. In the fourth quarter, Dynatronics showed an EPS of $0.63, compared to $0.50 from the year-ago quarter. The current stock performance of Dynatronics shows a 52-week-high of $2.73 and a 52-week-low of $0.69. Moreover, at the end of the last trading period, the closing price was at $0.69.

    B. Riley Securities downgraded the previous rating for Mirati Therapeutics Inc (NASDAQ:MRTX) from Buy to Neutral. Mirati Therapeutics earned $3.04 in the second quarter, compared to $3.18 in the year-ago quarter. At the moment, the stock has a 52-week-high of $101.20 and a 52-week-low of $27.30. Mirati Therapeutics closed at $60.20 at the end of the last trading period.

    For Apollo Global Management Inc (NYSE:APO), Oppenheimer downgraded the previous rating of Outperform to Perform. For the second quarter, Apollo Global Management had an EPS of $1.70, compared to year-ago quarter EPS of $0.94. The stock has a 52-week-high of $93.18 and a 52-week-low of $45.63. At the end of the last trading period, Apollo Global Management closed at $90.57.

    According to Oppenheimer, the prior rating for Blue Owl Capital Inc (NYSE:OWL) was changed from Outperform to Perform. For the second quarter, Blue Owl Cap had an EPS of $0.16, compared to year-ago quarter EPS of $0.13. The current stock performance of Blue Owl Cap shows a 52-week-high of $14.04 and a 52-week-low of $8.06. Moreover, at the end of the last trading period, the closing price was at $13.65.

    According to Raymond James, the prior rating for AeroVironment Inc (NASDAQ:AVAV) was changed from Strong Buy to Outperform. In the first quarter, AeroVironment showed an EPS of $1.00, compared to $0.10 from the year-ago quarter. The current stock performance of AeroVironment shows a 52-week-high of $124.33 and a 52-week-low of $74.91. Moreover, at the end of the last trading period, the closing price was at $105.02.

    For Datadog Inc (NASDAQ:DDOG), B of A Securities downgraded the previous rating of Buy to Neutral. In the second quarter, Datadog showed an EPS of $0.36, compared to $0.24 from the year-ago quarter. At the moment, the stock has a 52-week-high of $118.02 and a 52-week-low of $61.34. Datadog closed at $94.43 at the end of the last trading period.

    Evercore ISI Group downgraded the previous rating for Splunk Inc (NASDAQ:SPLK) from Outperform to In-Line. In the second quarter, Splunk showed an EPS of $0.71, compared to $0.09 from the year-ago quarter. At the moment, the stock has a 52-week-high of $147.14 and a 52-week-low of $65.00. Splunk closed at $146.70 at the end of the last trading period.

    For Zurn Elkay Water Solutions Corp (NYSE:ZWS), Goldman Sachs downgraded the previous rating of Buy to Neutral. Zurn Elkay Water earned $0.24 in the second quarter, compared to $0.32 in the year-ago quarter. At the moment, the stock has a 52-week-high of $30.87 and a 52-week-low of $19.29. Zurn Elkay Water closed at $26.46 at the end of the last trading period.

    According to Redburn Atlantic, the prior rating for Spotify Technology SA (NYSE:SPOT) was changed from Buy to Neutral. In the second quarter, Spotify Technology showed an EPS of $1.69, compared to $0.91 from the year-ago quarter. At the moment, the stock has a 52-week-high of $182.00 and a 52-week-low of $69.41. Spotify Technology closed at $160.53 at the end of the last trading period.

    According to Jefferies, the prior rating for Mirati Therapeutics Inc (NASDAQ:MRTX) was changed from Buy to Hold. Mirati Therapeutics earned $3.04 in the second quarter, compared to $3.18 in the year-ago quarter. The current stock performance of Mirati Therapeutics shows a 52-week-high of $101.20 and a 52-week-low of $27.30. Moreover, at the end of the last trading period, the closing price was at $60.20.

    Barclays downgraded the previous rating for Tenable Holdings Inc (NASDAQ:TENB) from Overweight to Equal-Weight. For the second quarter, Tenable Holdings had an EPS of $0.22, compared to year-ago quarter EPS of $0.05. The current stock performance of Tenable Holdings shows a 52-week-high of $49.77 and a 52-week-low of $28.80. Moreover, at the end of the last trading period, the closing price was at $46.15.

    For Mirati Therapeutics Inc (NASDAQ:MRTX), JMP Securities downgraded the previous rating of Market Outperform to Market Perform. In the second quarter, Mirati Therapeutics showed an EPS of $3.04, compared to $3.18 from the year-ago quarter. The stock has a 52-week-high of $101.20 and a 52-week-low of $27.30. At the end of the last trading period, Mirati Therapeutics closed at $60.20.

    See all analyst ratings downgrades.

    Initiations

    With a Buy rating, Jefferies initiated coverage on Laureate Education Inc (NASDAQ:LAUR). The price target seems to have been set at $20.00 for Laureate Education. For the second quarter, Laureate Education had an EPS of $0.35, compared to year-ago quarter EPS of $0.25. At the moment, the stock has a 52-week-high of $14.80 and a 52-week-low of $9.24. Laureate Education closed at $14.10 at the end of the last trading period.

    Loop Capital initiated coverage on ARM Holdings PLC (NASDAQ:ARM) with a Buy rating. The price target for ARM Holdings is set to $69.00. The stock has a 52-week-high of $69.00 and a 52-week-low of $49.85. At the end of the last trading period, ARM Holdings closed at $54.08.

    With a Buy rating, Rosenblatt initiated coverage on ARM Holdings PLC (NASDAQ:ARM). The price target seems to have been set at $85.00 for ARM Holdings. At the moment, the stock has a 52-week-high of $69.00 and a 52-week-low of $49.85. ARM Holdings closed at $54.08 at the end of the last trading period.

    Wolfe Research initiated coverage on ARM Holdings PLC (NASDAQ:ARM) with a Peer Perform rating. The current stock performance of ARM Holdings shows a 52-week-high of $69.00 and a 52-week-low of $49.85. Moreover, at the end of the last trading period, the closing price was at $54.08.

    B of A Securities initiated coverage on ARM Holdings PLC (NASDAQ:ARM) with a Buy rating. The price target for ARM Holdings is set to $65.00. The current stock performance of ARM Holdings shows a 52-week-high of $69.00 and a 52-week-low of $49.85. Moreover, at the end of the last trading period, the closing price was at $54.08.

    With an Outperform rating, BMO Capital initiated coverage on Prime Medicine Inc (NASDAQ:PRME). The price target seems to have been set at $19.00 for Prime Medicine. Prime Medicine earned $0.47 in the second quarter, compared to $1.76 in the year-ago quarter. At the moment, the stock has a 52-week-high of $21.60 and a 52-week-low of $8.46. Prime Medicine closed at $8.88 at the end of the last trading period.

    HC Wainwright & Co. initiated coverage on Scilex Holding Co (NASDAQ:SCLX) with a Buy rating. The price target for Scilex Holding is set to $12.00. For the second quarter, Scilex Holding had an EPS of $0.19, compared to year-ago quarter EPS of $0.13. At the moment, the stock has a 52-week-high of $16.90 and a 52-week-low of $1.21. Scilex Holding closed at $1.57 at the end of the last trading period.

    Mizuho initiated coverage on ARM Holdings PLC (NASDAQ:ARM) with a Buy rating. The price target for ARM Holdings is set to $62.00. The stock has a 52-week-high of $69.00 and a 52-week-low of $49.85. At the end of the last trading period, ARM Holdings closed at $54.08.

    With a Buy rating, Guggenheim initiated coverage on ARM Holdings PLC (NASDAQ:ARM). The price target seems to have been set at $64.00 for ARM Holdings. The stock has a 52-week-high of $69.00 and a 52-week-low of $49.85. At the end of the last trading period, ARM Holdings closed at $54.08.

    With an Outperform rating, TD Cowen initiated coverage on ARM Holdings PLC (NASDAQ:ARM). The price target seems to have been set at $63.00 for ARM Holdings. At the moment, the stock has a 52-week-high of $69.00 and a 52-week-low of $49.85. ARM Holdings closed at $54.08 at the end of the last trading period.

    Jefferies initiated coverage on ARM Holdings PLC (NASDAQ:ARM) with a Buy rating. The price target for ARM Holdings is set to $64.00. The current stock performance of ARM Holdings shows a 52-week-high of $69.00 and a 52-week-low of $49.85. Moreover, at the end of the last trading period, the closing price was at $54.08.

    Deutsche Bank initiated coverage on ARM Holdings PLC (NASDAQ:ARM) with a Buy rating. The price target for ARM Holdings is set to $60.00. At the moment, the stock has a 52-week-high of $69.00 and a 52-week-low of $49.85. ARM Holdings closed at $54.08 at the end of the last trading period.

    JP Morgan initiated coverage on ARM Holdings PLC (NASDAQ:ARM) with an Overweight rating. The price target for ARM Holdings is set to $70.00. The current stock performance of ARM Holdings shows a 52-week-high of $69.00 and a 52-week-low of $49.85. Moreover, at the end of the last trading period, the closing price was at $54.08.

    Baird initiated coverage on Calidi Biotherapeutics Inc (AMEX:CLDI) with an Outperform rating. The price target for Calidi Biotherapeutics is set to $9.00. The stock has a 52-week-high of $5.00 and a 52-week-low of $2.60. At the end of the last trading period, Calidi Biotherapeutics closed at $2.92.

    BMO Capital initiated coverage on ARM Holdings PLC (NASDAQ:ARM) with a Market Perform rating. The price target for ARM Holdings is set to $60.00. The current stock performance of ARM Holdings shows a 52-week-high of $69.00 and a 52-week-low of $49.85. Moreover, at the end of the last trading period, the closing price was at $54.08.

    Barclays initiated coverage on ARM Holdings PLC (NASDAQ:ARM) with an Overweight rating. The price target for ARM Holdings is set to $65.00. The stock has a 52-week-high of $69.00 and a 52-week-low of $49.85. At the end of the last trading period, ARM Holdings closed at $54.08.

    Citigroup initiated coverage on ARM Holdings PLC (NASDAQ:ARM) with a Buy rating. The price target for ARM Holdings is set to $65.00. At the moment, the stock has a 52-week-high of $69.00 and a 52-week-low of $49.85. ARM Holdings closed at $54.08 at the end of the last trading period.

    With a Buy rating, Goldman Sachs initiated coverage on ARM Holdings PLC (NASDAQ:ARM). The price target seems to have been set at $62.00 for ARM Holdings. The current stock performance of ARM Holdings shows a 52-week-high of $69.00 and a 52-week-low of $49.85. Moreover, at the end of the last trading period, the closing price was at $54.08.

    See all analyst ratings initiations.

    Get the next $APO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $APO
    $ARM
    $ARMK
    $AVAV

    CompanyDatePrice TargetRatingAnalyst
    Spotify Technology S.A.
    $SPOT
    2/11/2026$875.00 → $420.00Buy → Hold
    Pivotal Research Group
    Oracle Corporation
    $ORCL
    2/9/2026Buy → Hold
    Melius
    Oracle Corporation
    $ORCL
    2/9/2026$180.00Neutral → Buy
    DA Davidson
    MSC Industrial Direct Company Inc.
    $MSM
    2/6/2026$95.00Overweight → Neutral
    Analyst
    Arm Holdings plc
    $ARM
    2/5/2026Neutral → Buy
    New Street
    Oracle Corporation
    $ORCL
    2/4/2026$270.00 → $205.00Outperform
    BMO Capital Markets
    Spotify Technology S.A.
    $SPOT
    1/30/2026$650.00Neutral → Buy
    Citigroup
    Datadog Inc.
    $DDOG
    1/29/2026$215.00 → $170.00Outperform
    BMO Capital Markets
    More analyst ratings

    $APO
    $ARM
    $ARMK
    $AVAV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Spotify downgraded by Pivotal Research Group with a new price target

    Pivotal Research Group downgraded Spotify from Buy to Hold and set a new price target of $420.00 from $875.00 previously

    2/11/26 9:23:52 AM ET
    $SPOT
    Broadcasting
    Consumer Discretionary

    Oracle downgraded by Melius

    Melius downgraded Oracle from Buy to Hold

    2/9/26 9:24:14 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Oracle upgraded by DA Davidson with a new price target

    DA Davidson upgraded Oracle from Neutral to Buy and set a new price target of $180.00

    2/9/26 6:56:02 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $APO
    $ARM
    $ARMK
    $AVAV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CFO Mcdonnell Kevin Patrick sold $235,220 worth of shares (879 units at $267.60) (SEC Form 4)

    4 - AeroVironment Inc (0001368622) (Issuer)

    2/11/26 4:48:49 PM ET
    $AVAV
    Aerospace
    Industrials

    Chief Executive Officer Magouyrk Clayton M. sold $1,552,318 worth of shares (10,000 units at $155.23), decreasing direct ownership by 7% to 134,030 units (SEC Form 4)

    4 - ORACLE CORP (0001341439) (Issuer)

    2/11/26 4:42:45 PM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    Director Moore George C was granted 2,900 shares, increasing direct ownership by 2% to 119,632 units (SEC Form 4)

    4 - Zurn Elkay Water Solutions Corp (0001439288) (Issuer)

    2/10/26 8:43:42 PM ET
    $ZWS
    Industrial Machinery/Components
    Industrials

    $APO
    $ARM
    $ARMK
    $AVAV
    SEC Filings

    View All

    SEC Form S-8 filed by Spotify Technology S.A.

    S-8 - Spotify Technology S.A. (0001639920) (Filer)

    2/10/26 4:53:27 PM ET
    $SPOT
    Broadcasting
    Consumer Discretionary

    SEC Form 144 filed by Zurn Elkay Water Solutions Corporation

    144 - Zurn Elkay Water Solutions Corp (0001439288) (Subject)

    2/10/26 4:48:31 PM ET
    $ZWS
    Industrial Machinery/Components
    Industrials

    SEC Form 20-F filed by Spotify Technology S.A.

    20-F - Spotify Technology S.A. (0001639920) (Filer)

    2/10/26 4:26:10 PM ET
    $SPOT
    Broadcasting
    Consumer Discretionary

    $APO
    $ARM
    $ARMK
    $AVAV
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for KRAZATI issued to MIRATI THERAPEUTICS, INC

    Submission status for MIRATI THERAPEUTICS, INC's drug KRAZATI (ORIG-1) with active ingredient ADAGRASIB has changed to 'Approval' on 12/12/2022. Application Category: NDA, Application Number: 216340, Application Classification: Type 1 - New Molecular Entity

    12/14/22 7:40:10 AM ET
    $MRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for KRAZATI (ADAGRASIB) issued to MIRATI THERAPEUTICS, INC

    Submission status for MIRATI THERAPEUTICS, INC's drug KRAZATI (ADAGRASIB) (ORIG-1) with active ingredient ADAGRASIB has changed to 'Approval' on 12/12/2022. Application Category: NDA, Application Number: 216340, Application Classification: Type 1 - New Molecular Entity

    12/12/22 6:09:02 PM ET
    $MRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for KRAZATI (ADAGRASIB) issued to MIRATI THERAPEUTICS, INC

    Submission status for MIRATI THERAPEUTICS, INC's drug KRAZATI (ADAGRASIB) (ORIG-1) with active ingredient ADAGRASIB has changed to 'Approval' on 12/12/2022. Application Category: NDA, Application Number: 216340, Application Classification: Efficacy

    12/12/22 4:56:01 PM ET
    $MRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $APO
    $ARM
    $ARMK
    $AVAV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Oracle Health Clinical AI Agent, Clinical Note Helps UK Doctors Spend More Time on Patient Care

    AI-powered agent for clinical notes is now available in the UK after demonstrating significant benefits at NHS Trusts Oracle Health Clinical AI Agent reduces documentation time, freeing time for more meaningful patient interaction LONDON, Feb. 12, 2026 /PRNewswire/ -- Following a successful pilot program at several NHS Trusts, Oracle Health today announced its Clinical AI Agent, Clinical Note is now available in the UK. The new AI solution allows caregivers at the NHS and private practices to use an ambient voice and screen-driven assistant to draft patient notes, so they can reduce administrative tasks and devote more time to patient care. Trusts participating in the pilot program, includin

    2/12/26 4:15:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    AB InBev Reports Full Year and Fourth Quarter 2025 Results

    Underlying EPS increased by 6% with continued margin expansion and free cash flow generation of 11.3 billion USD Anheuser-Busch InBev (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD): This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260211688662/en/Figure 14. Terms and debt repayment schedule as of 31 December 2025 (billion USD) Regulated and inside information1 "Beer plays an important role in bringing people together and creating moments of celebration. In 2025, we executed our strategy, made disciplined capital allocation choices and delivered growth within our outlook for the year, even as we navigated a dynamic consumer envir

    2/12/26 1:01:00 AM ET
    $APO
    $BUD
    Investment Managers
    Finance
    Beverages (Production/Distribution)
    Consumer Staples

    Hillsboro Health Chooses AI-Powered Oracle Health Solutions to Help Advance Patient Care, Optimize Operations

    Will unify health record systems with Oracle Health Foundation EHR, implement Oracle Health Clinical AI Agent and Oracle Health Seamless Exchange across its network AUSTIN, Texas, Feb. 11, 2026 /PRNewswire/ -- Hillsboro Health, an independent, 25-bed critical access hospital based in Hillsboro, Illinois, has chosen Oracle Health solutions to help accelerate innovation, drive operational efficiencies, and enhance patient care. In addition to transitioning from legacy systems to an integrated Oracle Health Foundation EHR, Hillsboro Health plans to leverage Oracle Health Clinical AI Agent, an AI-powered, voice-driven solution, to automate clinical documentation and enable providers to dedicate

    2/11/26 8:05:00 AM ET
    $ORCL
    Computer Software: Prepackaged Software
    Technology

    $APO
    $ARM
    $ARMK
    $AVAV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Coviello Arthur W Jr bought $258,000 worth of shares (12,000 units at $21.50), increasing direct ownership by 30% to 51,731 units (SEC Form 4)

    4 - Tenable Holdings, Inc. (0001660280) (Issuer)

    2/9/26 4:06:46 PM ET
    $TENB
    Computer Software: Prepackaged Software
    Technology

    Co-Chief Executive Officer Ostrover Douglas I bought $2,379,469 worth of Class A Shares (158,000 units at $15.06) (SEC Form 4)

    4 - BLUE OWL CAPITAL INC. (0001823945) (Issuer)

    12/3/25 5:12:45 PM ET
    $OWL
    Investment Managers
    Finance

    Co-Chief Executive Officer Lipschultz Marc S bought $2,379,469 worth of Class A Shares (158,000 units at $15.06) (SEC Form 4)

    4 - BLUE OWL CAPITAL INC. (0001823945) (Issuer)

    12/3/25 5:10:40 PM ET
    $OWL
    Investment Managers
    Finance

    $APO
    $ARM
    $ARMK
    $AVAV
    Leadership Updates

    Live Leadership Updates

    View All

    AV Welcomes Stephen Voline as Senior Director, Washington Operations

    Experienced defense policy and government relations leader brings decades of military, legislative, and industry expertise to AV's Washington Operations team AeroVironment, Inc. ("AV") (NASDAQ:AVAV), a global defense technology leader, today announced that Stephen Voline has joined the company as Senior Director of Washington Operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260211855975/en/Stephen Voline brings more than three decades of experience across military operations, defense policy, and industry advocacy. Voline will support AV's engagement with Congress, the Department of War, and key national security stak

    2/11/26 7:30:00 AM ET
    $AVAV
    Aerospace
    Industrials

    Edgewater Wireless Issues 2026 Corporate Update

    "Wi-Fi8 Before Wi-Fi8" – Accelerating Wi-Fi8-ready Spectrum Slicing™ Silicon with Silicon Catalyst Ecosystem, Arm, Synopsys and FABrIC Support Edgewater Wireless Systems Inc. (TSXV:YFI) (OTC:KPIFF), the industry pioneer of AI-powered Wi-Fi Spectrum Slicing™ silicon solutions and IP for residential, enterprise and Industrial IoT markets, today issued a corporate update outlining the Company's material progress over the past 12 months and its 2026 execution roadmap toward Wi-Fi8-ready silicon deliverables and strategic commercialization. Over the last year, Edgewater has evolved from an innovation-led Wi-Fi disruptor into a globally recognized reliability and low-latency thought leader, a

    2/5/26 7:01:00 AM ET
    $ARM
    $SNPS
    Semiconductors
    Technology
    Computer Software: Prepackaged Software

    Calidi Biotherapeutics Provides Corporate Update and Key Value Drivers for 2026

    Company intends to file an IND in Q4 2026 for its first RedTail lead candidate, CLD-401, a systemically delivered and targeted genetic medicine engineered to deliver high concentrations of IL-15 superagonist to the tumor microenvironment in patients with metastatic disease.Calidi expects to present proof of concept data demonstrating the versatility of the RedTail platform and expanding its oncology platform with new payloads including the simultaneous delivery of tumor-localized BiTEs alongside T-cell amplifiers.Calidi expects to present proof of concept data demonstrating the applicability of the RedTail platform in non-oncology indications. SAN DIEGO, Jan. 28, 2026 (GLOBE NEWSWIRE) --

    1/28/26 8:00:00 AM ET
    $CLDI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $APO
    $ARM
    $ARMK
    $AVAV
    Financials

    Live finance-specific insights

    View All

    AB InBev Reports Full Year and Fourth Quarter 2025 Results

    Underlying EPS increased by 6% with continued margin expansion and free cash flow generation of 11.3 billion USD Anheuser-Busch InBev (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD): This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260211688662/en/Figure 14. Terms and debt repayment schedule as of 31 December 2025 (billion USD) Regulated and inside information1 "Beer plays an important role in bringing people together and creating moments of celebration. In 2025, we executed our strategy, made disciplined capital allocation choices and delivered growth within our outlook for the year, even as we navigated a dynamic consumer envir

    2/12/26 1:01:00 AM ET
    $APO
    $BUD
    Investment Managers
    Finance
    Beverages (Production/Distribution)
    Consumer Staples

    On to Release Fourth Quarter and Full Year 2025 Results on Tuesday, March 3, 2026

    Swiss performance sportswear brand On (NYSE:ONON) announced today that the Company will release its fourth quarter and full year 2025 financial results on Tuesday, Mar. 3, 2026 before U.S. financial markets open. The Company's management will host an earnings conference call and webcast at 8 a.m. U.S. Eastern Time on Mar. 3, 2026 (2 p.m. Central European Time). To access the live conference call by telephone, please dial the following numbers: United States: +1 646 307 19 63 United Kingdom: +44 203 481 42 47 Switzerland: +41 43 210 51 63 Conference ID: 5251715 Additionally, a live webcast of the conference call will be available on the Company's investor relations website and via th

    2/10/26 4:30:00 PM ET
    $ONON
    Shoe Manufacturing
    Consumer Discretionary

    Datadog Announces Fourth Quarter and Fiscal Year 2025 Financial Results

    Fourth quarter revenue grew 29% year-over-year to $953 million Strong growth of larger customers, with 603 $1 million+ ARR customers, up from 462 a year ago Launched Bits AI SRE Agent, Storage Management, Feature Flags, and Data Observability for general availability NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Datadog, Inc. (NASDAQ:DDOG), the AI-powered observability and security platform for cloud applications, today announced financial results for its fourth quarter and fiscal year ended December 31, 2025. "We are pleased with our strong execution in fiscal year 2025, with 28% year-over-year revenue growth, $1,050 million in operating cash flow, and $915 milli

    2/10/26 7:00:00 AM ET
    $DDOG
    Computer Software: Prepackaged Software
    Technology

    $APO
    $ARM
    $ARMK
    $AVAV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Prime Medicine Inc.

    SC 13D/A - Prime Medicine, Inc. (0001894562) (Subject)

    11/22/24 5:32:53 PM ET
    $PRME
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Blue Owl Capital Inc.

    SC 13G/A - BLUE OWL CAPITAL INC. (0001823945) (Subject)

    11/14/24 5:24:34 PM ET
    $OWL
    Investment Managers
    Finance

    Amendment: SEC Form SC 13G/A filed by Calidi Biotherapeutics Inc.

    SC 13G/A - Calidi Biotherapeutics, Inc. (0001855485) (Subject)

    11/14/24 2:05:25 PM ET
    $CLDI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care